Article
Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients.
Journal of clinical pharmacology - 1 Nov 2013
Gómez-Bravo Miguel Angel, Salcedo Magdalena, Fondevila Constantino, Suarez Francisco, Castellote José, Rufian Sebastián, Pons José Antonio, Alamo José María, Millán Olga, Brunet Mercè
Abstract excerpt
Studies of liver transplant (LT) patients, mainly in Asians, have evaluated the influence of the CYP3A5*1 allele and P-glycoprotein gene ABCB1 on tacrolimus pharmacokinetics or biopsy-proven acute rejection (BPAR) incidence, with no conclusive results. To investigate these issues, 98 Caucasian Spanish LT patients with tacrolimus, mycophenolate mofetil and steroids and 88 cadaveric donors were genotyped for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
